Outlook Therapeutics Ltd
08179857
Some Concerns
- No accounts filed in last 18 months (-5)
Details
Compliance
Last accounts
30/09/2024
dormant
Next accounts due
30/06/2026
Confirmation statement
Last: 31/08/2025
Due 14/09/2026
Industry
Officers
Persons with Significant Control
Outlook Therapeutics Nl B.V.
Strawinskylaan, 569, 1077xx
Reg: 98096060 · Trade Register (Handelsregister) · Dutch Besloten Vennootschap
Notified 06/11/2025
Former PSCs
Outlook Therapeutics, Inc.
Ceased 06/11/2025
CompanyRankvs 2074+ SIC 72110 peers42
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/08/2023
Net Worth
£1k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
—
Working capital
Current Assets
—
Current Liabilities
—
Debtors
£1k